Cipla Ltd.

Cipla’s wholly owned subsidiary in Netherlands - Cipla Holding B. V. (Cipla Netherlands), has entered into a joint venture agreement (JVA) with Ahran Tejarat Company to incorporate a joint venture company. As per the joint venture agreement, Cipla Netherlands will hold a 75% stake in a joint venture company in Iran while the JV Partner shall hold the remaining 25% stake. 

The total expected investment of Cipla Netherlands in cash in the joint venture company is estimated at being up to a maximum of 16.875 million euro. The joint venture company proposes to undertake manufacturing and marketing of pharmaceutical products in Iran.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 100 countries.